# ATF7IP2

## Overview
ATF7IP2, or activating transcription factor 7 interacting protein 2, is a gene that encodes a protein involved in chromatin remodeling and gene regulation, particularly within the male germline. The protein encoded by ATF7IP2 is a key player in the regulation of H3K9 methylation, a critical histone modification associated with transcriptional repression. It interacts with the histone methyltransferase SETDB1 to facilitate the deposition of H3K9me3, thereby maintaining heterochromatin structure and regulating gene expression during meiosis. This protein is essential for the progression of spermatocytes and is implicated in the regulation of transposable elements, contributing to genomic stability. Additionally, ATF7IP2 is involved in immune signaling pathways, interacting with various proteins to form transcriptionally silent heterochromatin domains, which are crucial for immune regulation (Alavattam2023ATF7IP2MCAF2; Huang2024Target).

## Function
ATF7IP2, also known as MCAF2, is a critical regulator of H3K9 methylation and gene regulation in the male germline. It plays a significant role in the organization of spermatogenic heterochromatin by accumulating on autosomal and X pericentric heterochromatin and spreading through the sex chromosomes. ATF7IP2 is involved in the recruitment of SETDB1, a histone methyltransferase, to X pericentric heterochromatin during male meiosis, facilitating the deposition of H3K9me3, a key histone modification (Alavattam2023ATF7IP2MCAF2).

In healthy human cells, ATF7IP2 is highly expressed in meiotic spermatocytes and is essential for the progression of spermatocytes beyond the mid pachytene stage. Its absence leads to infertility and testicular defects, highlighting its critical role in male germline development (Alavattam2023ATF7IP2MCAF2). ATF7IP2 also regulates the expression of transposable elements and protein-coding genes on autosomes and sex chromosomes, maintaining transcriptional repression on sex chromosomes during meiosis (Alavattam2023ATF7IP2MCAF2). The gene functions as a downstream effector of the DNA damage response pathway, coordinating heterochromatin organization and gene regulation through SETDB1-mediated H3K9me3 deposition (Alavattam2023ATF7IP2MCAF2).

## Interactions
ATF7IP2, also known as activating transcription factor 7 interacting protein 2, is involved in several protein-protein interactions that play a crucial role in chromatin remodeling and gene regulation. It interacts with the histone methyltransferase SETDB1, facilitating the deposition of H3K9me3, a key mark for transcriptional repression. This interaction is essential for the regulation of meiotic genes and the maintenance of heterochromatin in male germline cells (Alavattam2023ATF7IP2MCAF2).

ATF7IP2 is also implicated in the regulation of transposable elements, with its absence leading to the upregulation of certain transposable elements, indicating its role in maintaining genomic stability (Alavattam2023ATF7IP2MCAF2). The protein is recruited to X pericentric heterochromatin through the DNA damage response pathway, where it coordinates with SETDB1 to regulate heterochromatin organization (Alavattam2023ATF7IP2MCAF2).

In the context of immune signaling, ATF7IP2 interacts with proteins such as MBD1, SETDB1, and SP1, forming transcriptionally silent heterochromatin domains. These interactions are crucial for immune regulation and are affected by genetic variants in the CLEC16A locus, which is associated with common variable immunodeficiency (Huang2024Target).


## References


1. (Alavattam2023ATF7IP2MCAF2) ATF7IP2/MCAF2 directs H3K9 methylation and meiotic gene regulation in the male germline. This article has 0 citations.

[2. (Huang2024Target) Xubo Huang, Jinxia Huang, Xiumei Li, Jingxian Fan, Desheng Zhou, Hui-Qi Qu, Joseph T. Glessner, Dandan Ji, Qi Jia, Zhiyong Ding, Nan Wang, Wei Wei, Xing Lyu, Mulin Jun Li, Zhe Liu, Wei Liu, Yongjie Wei, Hakon Hakonarson, Qianghua Xia, and Jin Li. Target genes regulated by clec16a intronic region associated with common variable immunodeficiency. Journal of Allergy and Clinical Immunology, 153(6):1668â€“1680, June 2024. URL: http://dx.doi.org/10.1016/j.jaci.2023.12.023, doi:10.1016/j.jaci.2023.12.023. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2023.12.023)